ALDX
Aldeyra Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Aldeyra Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Knoll Capital ManagementKnoll | $11.7M | 14.72% | 0.00% | |
| 2 | AQR Capital ManagementAQR | $8.0M | 10.09% | +32.57% | |
| 3 | Kingdon Capital ManagementKingdon | $5.6M | 7.13% | +23.23% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $5.0M | 6.35% | −0.08% | |
| 5 | D. E. ShawD. E. Shaw | $4.1M | 5.22% | +38.20% | |
| 6 | Marshall WaceMarshall Wace | $3.2M | 4.05% | +1061.95% | |
| 7 | 683 Capital Management683 Capital Management | $3.1M | 3.90% | −3.33% | |
| 8 | Jane Street GroupJane Street | $3.0M | 3.75% | +22.39% | |
| 9 | Ardsley Advisory PartnersArdsley Advisory Partners | $2.7M | 3.43% | +2.00% | |
| 10 | BlackRockBlackRockindex-like | $2.7M | 3.38% | −66.60% | |
| 11 | Qube Research & TechnologiesQube Research & Technologies | $2.4M | 3.04% | +1196.31% | |
| 12 | Acadian Asset ManagementAcadian | $2.3M | 2.86% | +23.94% | |
| 13 | Renaissance TechnologiesRenaissance Technologies | $1.9M | 2.37% | +2.18% | |
| 14 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.7M | 2.14% | −1.60% | |
| 15 | Goldman Sachs GroupGoldman Sachs | $1.5M | 1.95% | +33.56% | |
| 16 | Jacobs Levy Equity ManagementJacobs Levy Equity | $1.4M | 1.74% | −18.82% | |
| 17 | Morgan StanleyMorgan Stanley | $1.3M | 1.64% | +17.29% | |
| 18 | Geode Capital ManagementGeodeindex-like | $1.3M | 1.60% | −52.38% | |
| 19 | Citadel AdvisorsCitadel | $1.2M | 1.46% | +30.20% | |
| 20 | Dimensional Fund AdvisorsDimensional | $1.1M | 1.42% | −15.23% | |
| 21 | GSA Capital PartnersGSA Capital Partners | $1.0M | 1.27% | +91.17% | |
| 22 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $897,109 | 1.13% | new | |
| 23 | Millennium ManagementMillennium | $767,546 | 0.97% | −63.79% | |
| 24 | UBS GroupUBS | $643,132 | 0.81% | −43.83% | |
| 25 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $635,255 | 0.80% | −11.92% |
106 managers report $79.2M of Aldeyra Therapeutics on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; Knoll is largest at 14.72%.
No implied move.
No implied move.
Expected move
No implied move.
Aldeyra Therapeutics, Inc.
0.66
0.00 · +0.73%
post 0.57 −13.86%